European equities traded in the US as American depositary receipts were tracking higher late Friday morning, rising 0.55% to 1,910.34 on the S&P Europe Select ADR Index, which is up about 0.4% for the week so far.
From continental Europe, the gainers were led by software firm SAP (SAP) and semiconductor company Sequans Communications (SQNS), which rose 7% and 2.8%, respectively. They were followed by pharmaceutical firm Novo Nordisk (NVO) and lender Banco Santander (SAN), which advanced 2.5% and 2.4%, respectively.
The decliners from continental Europe were led by telecommunications company Nokia (NOK) and biopharmaceutical company DBV Technologies (DBVT), which dropped 4.7% and 2.9% respectively. They were followed by internet ad firm Criteo (CRTO) and biotech company BioNTech (BNTX), which lost 2.1% and 1.3% respectively.
The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and communications company WPP (WPP), which increased 3.7% and 2.3% respectively. They were followed by medical device maker Smith & Nephew (SNN) and educational publisher Pearson (PSO), which were up 1.7% and 1.6% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which fell 4.7% and 3% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Autolus Therapeutics (AUTL), which were down 2.5% and 2% respectively.